Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cartell Chemical is a leading global manufacturer of cyanoacrylate adhesives, primarily known for its flagship brand MXBON. While serving industrial and consumer markets, the company has a significant presence in the healthcare sector through its production of medical-grade adhesives used for wound closure and surgical applications. Their medical products are designed to provide rapid, needle-free closure of surgical incisions and lacerations, offering a biocompatible alternative to traditional sutures and staples. The company operates advanced manufacturing facilities in Taiwan and maintains ISO 13485 certification for medical device quality management. Cartell Chemical is one of the few global entities capable of producing the high-purity monomers required for specialized medical and electronic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cartell Chemical.